Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
primary-cta The Direction of Future Research Ongoing studies continue to expand our understanding of both peptides' potential applications
While complete reversal is challenging, early intervention with the right supplements, diet, and exercise program can significantly improve bone density and reduce fracture risk
Influence of acetyl-L-carnitine infusion on haemodynamic parameters and survival of circulatory-shock patients
Integrative Peptides' best-selling product, BPC-157, contains 500mcg of the systemically active, multi-function peptide in a new peppermint-flavored oral spray format.*
A 2021 phase 2 trial published in The New England Journal of Medicine showed semaglutide 2.4 mg achieved NASH resolution without worsening fibrosis in 59% of patients versus 17% on placebo (Newsome et al., NEJM 2021)
Gaucher C, Boudier A, Bonetti J, Clarot I, Leroy P, Parent M
.webp?t=1743535811)
US$ 27.57
US$ 27.91
US$ 26.83
US$ 25.27
US$ 21.40
US$ 26.64
US$ 22.92
US$ 22.82
